JP2022119852A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022119852A5 JP2022119852A5 JP2022081736A JP2022081736A JP2022119852A5 JP 2022119852 A5 JP2022119852 A5 JP 2022119852A5 JP 2022081736 A JP2022081736 A JP 2022081736A JP 2022081736 A JP2022081736 A JP 2022081736A JP 2022119852 A5 JP2022119852 A5 JP 2022119852A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pharmaceutically acceptable
- tautomer
- stereoisomer
- geometric isomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611211589.5A CN108239075B (zh) | 2016-12-26 | 2016-12-26 | 喹唑啉类化合物及其制备方法、用途和药物组合物 |
| CN201611214102.9A CN108239076B (zh) | 2016-12-26 | 2016-12-26 | 喹唑啉类化合物及其制备方法、用途和药物组合物 |
| CN201611214102.9 | 2016-12-26 | ||
| CN201611204309.8A CN108239074B (zh) | 2016-12-26 | 2016-12-26 | 喹唑啉类化合物及其制备方法、用途和药物组合物 |
| CN201611211589.5 | 2016-12-26 | ||
| CN201611204309.8 | 2016-12-26 | ||
| JP2019534817A JP7077323B2 (ja) | 2016-12-26 | 2017-12-26 | キナゾリン化合物並びにその調製方法、使用及び医薬組成物 |
| PCT/CN2017/118771 WO2018121550A1 (zh) | 2016-12-26 | 2017-12-26 | 喹唑啉类化合物及其制备方法、用途和药物组合物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019534817A Division JP7077323B2 (ja) | 2016-12-26 | 2017-12-26 | キナゾリン化合物並びにその調製方法、使用及び医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022119852A JP2022119852A (ja) | 2022-08-17 |
| JP2022119852A5 true JP2022119852A5 (cg-RX-API-DMAC7.html) | 2022-11-09 |
| JP7384535B2 JP7384535B2 (ja) | 2023-11-21 |
Family
ID=62707834
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019534817A Active JP7077323B2 (ja) | 2016-12-26 | 2017-12-26 | キナゾリン化合物並びにその調製方法、使用及び医薬組成物 |
| JP2022081736A Active JP7384535B2 (ja) | 2016-12-26 | 2022-05-18 | キナゾリン化合物並びにその調製方法、使用及び医薬組成物 |
| JP2022081738A Active JP7384536B2 (ja) | 2016-12-26 | 2022-05-18 | キナゾリン化合物並びにその調製方法、使用及び医薬組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019534817A Active JP7077323B2 (ja) | 2016-12-26 | 2017-12-26 | キナゾリン化合物並びにその調製方法、使用及び医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022081738A Active JP7384536B2 (ja) | 2016-12-26 | 2022-05-18 | キナゾリン化合物並びにその調製方法、使用及び医薬組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US11534443B2 (cg-RX-API-DMAC7.html) |
| EP (3) | EP4169918B8 (cg-RX-API-DMAC7.html) |
| JP (3) | JP7077323B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN110382490A (cg-RX-API-DMAC7.html) |
| AU (3) | AU2017389818B2 (cg-RX-API-DMAC7.html) |
| CA (3) | CA3048546A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018121550A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4169918B8 (en) * | 2016-12-26 | 2025-09-24 | Institute of Materia Medica, Chinese Academy of Medical Sciences | Quinazoline derivatives as inhibitors of pi3k for the treatment of cancer |
| CN114555588B (zh) * | 2019-11-07 | 2024-08-06 | 南京正大天晴制药有限公司 | 作为axl抑制剂的喹唑啉类化合物 |
| CN113620976B (zh) * | 2020-05-09 | 2023-09-26 | 中国医学科学院药物研究所 | 噻唑并嘧啶类化合物及其制备方法、用途和药物组合物 |
| PE20231311A1 (es) | 2020-11-18 | 2023-08-24 | Deciphera Pharmaceuticals Llc | Inhibidores de gcn2 y perk quinasas y metodos de uso de los mismos |
| MX2024006627A (es) | 2021-12-03 | 2024-08-22 | Deciphera Pharmaceuticals Llc | Inhibidores de gcn2 y perk quinasa y metodos de uso de los mismos. |
| TW202416953A (zh) * | 2022-08-26 | 2024-05-01 | 日商衛材R&D企管股份有限公司 | 抗體藥物複合物 |
| CA3223670C (en) | 2023-03-30 | 2026-05-26 | Sunstack, Llc | Trestle |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR960008781B1 (ko) * | 1993-08-05 | 1996-07-03 | 김하운 | 연소효율 증강장치 |
| DE60144277D1 (de) | 2000-04-25 | 2011-05-05 | Icos Corp | Hemmer der menschlichen phosphatidyl-inositol-3-kinase delta |
| TW200902008A (en) | 2007-05-10 | 2009-01-16 | Smithkline Beecham Corp | Quinoxaline derivatives as PI3 kinase inhibitors |
| PE20090717A1 (es) | 2007-05-18 | 2009-07-18 | Smithkline Beecham Corp | Derivados de quinolina como inhibidores de la pi3 quinasa |
| UY31137A1 (es) * | 2007-06-14 | 2009-01-05 | Smithkline Beecham Corp | Derivados de quinazolina como inhibidores de la pi3 quinasa |
| JP2011500823A (ja) | 2007-10-22 | 2011-01-06 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | Pi3キナーゼ阻害物質としてのピリドスルホンアミド誘導体 |
| CN105283454B (zh) * | 2013-04-12 | 2019-10-29 | 阿萨纳生物科技有限责任公司 | 作为ras/raf/mek/erk和pi3k/akt/pten/mtor通路双重抑制剂的喹唑啉和氮杂喹唑啉 |
| CN108239076B (zh) * | 2016-12-26 | 2021-07-06 | 中国医学科学院药物研究所 | 喹唑啉类化合物及其制备方法、用途和药物组合物 |
| EP4169918B8 (en) * | 2016-12-26 | 2025-09-24 | Institute of Materia Medica, Chinese Academy of Medical Sciences | Quinazoline derivatives as inhibitors of pi3k for the treatment of cancer |
| CN108239075B (zh) * | 2016-12-26 | 2021-07-02 | 中国医学科学院药物研究所 | 喹唑啉类化合物及其制备方法、用途和药物组合物 |
| CN108239074B (zh) * | 2016-12-26 | 2021-07-06 | 中国医学科学院药物研究所 | 喹唑啉类化合物及其制备方法、用途和药物组合物 |
-
2017
- 2017-12-26 EP EP22213594.9A patent/EP4169918B8/en active Active
- 2017-12-26 EP EP17886474.0A patent/EP3560921B1/en active Active
- 2017-12-26 CA CA3048546A patent/CA3048546A1/en active Pending
- 2017-12-26 CA CA3174865A patent/CA3174865A1/en active Pending
- 2017-12-26 CA CA3174890A patent/CA3174890A1/en active Pending
- 2017-12-26 CN CN201780075753.0A patent/CN110382490A/zh active Pending
- 2017-12-26 JP JP2019534817A patent/JP7077323B2/ja active Active
- 2017-12-26 EP EP22213583.2A patent/EP4169917B1/en active Active
- 2017-12-26 AU AU2017389818A patent/AU2017389818B2/en active Active
- 2017-12-26 WO PCT/CN2017/118771 patent/WO2018121550A1/zh not_active Ceased
- 2017-12-26 US US16/473,901 patent/US11534443B2/en active Active
-
2022
- 2022-04-30 AU AU2022202885A patent/AU2022202885B2/en active Active
- 2022-04-30 AU AU2022202886A patent/AU2022202886B2/en active Active
- 2022-05-18 JP JP2022081736A patent/JP7384535B2/ja active Active
- 2022-05-18 JP JP2022081738A patent/JP7384536B2/ja active Active
- 2022-09-13 US US17/944,151 patent/US12508264B2/en active Active
- 2022-09-13 US US17/944,149 patent/US12508263B2/en active Active